Cargando...
Biosimilar insulins: guidance for data interpretation by clinicians and users
Biosimilar insulins are approved copies of insulins outside patent protection. Advantages may include greater market competition and potential cost reduction, but clinicians and users lack a clear perspective on ‘biosimilarity’ for insulins. The manufacturing processes for biosimilar insulins are ma...
Gardado en:
| Publicado en: | Diabetes Obes Metab |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Blackwell Publishing Ltd
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4744724/ https://ncbi.nlm.nih.gov/pubmed/25974131 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.12491 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|